The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)

March 1, 2012 updated by: Michael Pelekanos MD

The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Study Overview

Status

Unknown

Conditions

Detailed Description

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: michael j pelekanos, MD
  • Phone Number: 4128567500
  • Email: mipels@aol.com

Study Contact Backup

Study Locations

  • United States
    • Pennsylvania
      • Monroeville, Pennsylvania, United States, 15146
        • Recruiting
        • East Suburban Obgyn
        • Contact:
          • Michael J Pelekanos, MD
          • Phone Number: 412-779-1034
          • Email: mipels@aol.com
        • Contact:
        • Principal Investigator:
          • michael j pelekanos, md
      • Monroeville, Pennsylvania, United States, 15146
        • Recruiting
        • West Penn Allegheny Health Center
        • Principal Investigator:
          • michael j pelekanos, md
        • Contact:
          • pelekanos
          • Phone Number: 412-856-7500
        • Contact:
          • vickie lathom
          • Phone Number: 4128567500
      • Monroeville, Pennsylvania, United States, 15146
        • Recruiting
        • West Penn Hospital Forbes Campus
        • Principal Investigator:
          • michael j pelekanos, md
        • Contact:
          • michael j pelekanos, md
          • Phone Number: 412-856-7500
          • Email: mipels@aol.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent

Description

Inclusion Criteria:

  • Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

  • Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Michael Pelekanos MD

Collaborators

West Penn Allegheny Health System

Investigators

  • Principal Investigator: michael j pelekanos, MD, east surburban obgyn

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2010

Primary Completion (Actual)

March 1, 2012

Study Completion (Anticipated)

July 1, 2012

Study Registration Dates

First Submitted

March 1, 2010

First Submitted That Met QC Criteria

March 1, 2010

First Posted (Estimate)

March 2, 2010

Study Record Updates

Last Update Posted (Estimate)

March 2, 2012

Last Update Submitted That Met QC Criteria

March 1, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 10-005

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Sexual Dysfunction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe